Literature DB >> 11005207

Lethal Mycobacterium bovis Bacillus Calmette Guérin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2.

I Garcia1, R Guler, D Vesin, M L Olleros, P Vassalli, Y Chvatchko, M Jacobs, B Ryffel.   

Abstract

The role of nitric oxide (NO) in Mycobacterium bovis Bacillus Calmette Guerin (BCG) infection was investigated using nitric oxide synthase 2 (nos2)-deficient mice, because NO plays a pivotal protective role in M. tuberculosis infection. We demonstrate that nos2-deficient mice were unable to eliminate BCG and succumbed within 8 to 12 weeks to BCG infection (10(6) CFU) with cachexia and pneumonia, whereas all infected wild-type mice survived. The greatest mycobacterial loads were observed in lung and spleen. Nos2-deficient mice developed large granulomas consisting of macrophages and activated T cells and caseous necrotic lesions in spleen. The macrophages in granulomas from nos2-deficient mice had reduced acid phosphatase activities, suggesting that NO is required for macrophage activation. The absence of NOS2 affected the cytokine production of the Th1 type of immune response, except IL-18. Serum amounts of IL-12p40 were increased and IFN-gamma was decreased compared with wild-type mice. The lack of NOS2 resulted in an overproduction of TNF, observed throughout the infection period. Additionally, TNFR1 and TNFR2 shedding was altered compared with wild-type mice. Up-regulation of TNF may be compensatory for the lack of NOS2. The late neutralization of TNF by soluble TNF receptors resulted in heightened disease severity and accelerated death in nos2-deficient mice but had no effect in wild-type mice. In conclusion, the inability of nos2-deficient mice to kill M. bovis BCG resulted in an accumulation of mycobacteria with a dramatic activation of the immune system and overproduction of pro-inflammatory cytokines, which resulted in death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005207     DOI: 10.1038/labinvest.3780146

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  30 in total

1.  Interferon-alphabeta mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection.

Authors:  John Kuchtey; Scott A Fulton; Scott M Reba; Clifford V Harding; W Henry Boom
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

2.  The CFP-10/ESAT-6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-gamma signaling.

Authors:  Si Guo; Lang Bao; Zi Fang Qin; Xin Xin Shi
Journal:  Med Microbiol Immunol       Date:  2010-03-16       Impact factor: 3.402

3.  Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.

Authors:  Roanne Keeton; Nasiema Allie; Ivy Dambuza; Brian Abel; Nai-Jen Hsu; Boipelo Sebesho; Philippa Randall; Patricia Burger; Elizabeth Fick; Valerie F J Quesniaux; Bernhard Ryffel; Muazzam Jacobs
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

4.  Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.

Authors:  Maria L Olleros; Reto Guler; Dominique Vesin; Roumen Parapanov; Gilles Marchal; Eduardo Martinez-Soria; Nadia Corazza; Jean-Claude Pache; Christoph Mueller; Irene Garcia
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

5.  Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection.

Authors:  Reto Guler; Maria L Olleros; Dominique Vesin; Roumen Parapanov; Irene Garcia
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Control of Mycobacterial Infections in Mice Expressing Human Tumor Necrosis Factor (TNF) but Not Mouse TNF.

Authors:  Maria L Olleros; Leslie Chavez-Galan; Noria Segueni; Marie L Bourigault; Dominique Vesin; Andrey A Kruglov; Marina S Drutskaya; Ruth Bisig; Stefan Ehlers; Sahar Aly; Kerstin Walter; Dmitry V Kuprash; Miliana Chouchkova; Sergei V Kozlov; François Erard; Bernard Ryffel; Valérie F J Quesniaux; Sergei A Nedospasov; Irene Garcia
Journal:  Infect Immun       Date:  2015-06-29       Impact factor: 3.441

Review 7.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 8.  Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.

Authors:  Joseph E Qualls; Peter J Murray
Journal:  Semin Immunopathol       Date:  2015-10-21       Impact factor: 9.623

9.  Reactive nitrogen intermediates have a bacteriostatic effect on Mycobacterium tuberculosis in vitro.

Authors:  Marcia A Firmani; Lee W Riley
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

10.  Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection.

Authors:  Nasiema Allie; Lena Alexopoulou; Valerie J F Quesniaux; Lizette Fick; Ksanthi Kranidioti; George Kollias; Bernhard Ryffel; Muazzam Jacobs
Journal:  Immunology       Date:  2008-06-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.